The results confirmed that the variant allele G of MDM2 rs2279744 was present in 61.9% of RCC patients, significantly higher than in the control group (52.1%) (OR = 1.49, 95% CI = 1.14–1.95, p = 0.0047), corroborating the findings from Table 3. The gene discussed is MDM2; the disease is renal cell carcinoma.